NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DISCO Pharmaceuticals

DISCO Pharmaceuticals

Private
CologneHealthcare & Life Scienceshttps://discopharma.de/

Last Round

Seed

Dec 11, 2025

Total Funding Raised

$63.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DISCO Pharmaceuticals is a biotechnology company that operates a surfaceome mapping platform designed to identify novel cancer-selective targets for the development of antibody-based therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

drug discoveryproteomicsprecision oncologycell surface proteinssurfaceomeantibody therapeuticsbiotech platformtarget identificationcomputational biologydrug pipelinebiopharma partnershipsmass spectrometrydrug discovery platformtarget discoverybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DISCO Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

DISCO Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DISCO Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 11, 2025
SeedJan 16, 2024

Key People

Founding team and executive leadership

Johannes Heuckmann

Chief Operating Officer (COO) And Founder

Founding Team

Mark Manfredi

Chief Executive Officer

Executive Team

DISCO Pharmaceuticals Investors

Notable investors and investment history

DISCO Pharmaceuticals investors
InvestorRounds
Ackermans & van HaarenSeed
M VenturesSeed
AbbVie VenturesSeed
Panakès PartnersSeed
NRW.BankSeed
Sofinnova PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 102% MoM, reaching 3.6K.

  • Dec 11, 2025

    $42M round led by Ackermans & van Haaren and Sofinnova Partners.

DISCO Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DISCO Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DISCO Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersCologne
Employee Range37
Year Founded2022
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.